ICMI 2015

T.52 The polysaccharides derived from Ganoderma lucidum fungus mycelia (designated as MAK) ameliorate indomethacin-induced small intestinal injuries through GM-CSF

Thursday, July 16, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Kenta Nagai, MD , Departments of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan
Yoshitaka Ueno, PhD , Endoscopy, Hiroshima University, Hiroshima, Japan
Shinji Tanaka, PhD , Endoscopy, Hiroshima University, Hiroshima, Japan
Shintaro Sagami, MD , Hiroshima University Hospital, Hiroshima, Japan
Soki Nishiyama, MD , Departments of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan
Kei Shinagawa, PhD , Hiroshima University Hospital, Hiroshima, Japan
Shiro Oka, PhD , Endoscopy, Hiroshima University, Hiroshima, Japan
Toru Hiyama, PhD , Health Service Center, Hiroshima University, Higashihiroshima, Japan
Masanori Ito, PhD , Departments of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan
Yasuhiko Kitadai, PhD , Departments of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan
Masaharu Yoshihara, PhD , Health Service Center, Hiroshima University, Higashihiroshima, Japan
Kazuaki Chayama, PhD , Hiroshima University Hospital, Hiroshima, Japan
Ryohei Hayashi, MD , Departments of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan
Introduction: Non-steroidal anti-inflammatory drugs often cause ulcers in the human small intestine, but few effective agents exist to treat such injury. “Ganoderma lucidum” Karst, also known as “Reishi”, is a mushroom. We previously reported that a water-soluble extract from G.lucidumfungus mycelia (MAK) has anti-inflammatory effects in murine colitis. However, its effects on indomethacin-induced small intestinal injuries are unknown. The present study investigated the preventative effects of the polysaccharides derived from MAK on indomethacin-induced small intestinal injuries in mice.

Methods: Peritoneal macrophages (PMs) were stimulated in vitro with MAK, and adoptively transferred to C57BL/6 mice intraperitoneally, which were then given indomethacin. Intestinal inflammation was evaluated after 24 hours. We performed in vivo antibody blockade to investigate the preventive role of GM-CSF, which derived from PMs stimulated with MAK. We then used PMs stimulated with MAK pre-treated by pectinase in an adoptive transfer assay to investigate the preventive role of polysaccharides.

Results: Indomethacin-induced small intestinal injury was inhibited by adoptive transfer of PMs stimulated in vitro with MAK. In this transfer model, pre-treatment with anti-GM-CSF antibody reversed the improvement of small intestinal inflammation by indomethacin. PMs stimulated with pectinase-pretreated MAK impaired the anti-inflammatory effect of MAK.

Conclusion: PMs stimulated by MAK appear to contribute to the anti-inflammatory response through GM-CSF in small intestinal injury induced by indomethacin. The polysaccharides from G.lucidum may elicit anti-inflammatory effect.